OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Officer sold ~$1.76M

Arthur C Butcher, Officer at Boston Scientific, sold ~$1.76M of Boston Scientific shares.

~$1.76M
Approx. value · 17K sh @ $101.55
24K
Holds after · shares reported
Traded
Dec 1, 2025
Filed
Dec 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 23, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  2. Oct 17, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  3. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  4. Oct 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 22, 2025, John E. Sununu informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
  5. Oct 27, 2025InsiderDirector sold ~$1.01M of BSX shares in the open market
  6. Oct 28, 2025InsiderDirector sold ~$297K of BSX shares in the open market
  7. Oct 28, 2025CongressDisclosed partial sale of BSX — reported range $15,001 - $50,000
  8. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  9. Oct 31, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  10. Nov 3, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  11. Nov 6, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  12. Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, upon the recommendation of the Executive Compensation and Human Resources Committee (the “Compensation Committee”), the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) approved the Company’s 2026 Annual Bonus Plan effective for the performance year of January 1, 2026 through December 31, 2026 (the “2026 Annual Bonus Plan”).”
  13. Nov 18, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  14. Dec 1, 2025 · this disclosureInsiderOfficer sold ~$1.76M of BSX shares in the open market

What came next

  1. Dec 16, 2025Federal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
  2. Dec 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  3. Dec 19, 2025FDARecall: HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 6mm x 8mm; Material Number (UPN): M00553520;
  4. Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 20mm x 10mm; Material Number (UPN): M00553660;
  5. Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 20mm x 10mm; Material Number (UPN): M00553560;
  6. Dec 19, 2025FDARecall: AXIOS Stent and Electrocautery-Enhanced Delivery System - 6mm x 8mm; Material Number (UPN): M00553680;
  7. Dec 19, 2025FDARecall: *HOT AXIOS Stent and Electrocautery-Enhanced Delivery System 8mm x 8mm; Material Number (UPN): M00553530;
  8. Dec 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  9. Dec 29, 2025CongressDisclosed purchase of BSX — reported range $15,001 - $50,000
  10. Jan 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  11. Jan 23, 2026FDAFDA device clearance: BodyGuardian Remote Monitoring System (BGRMS v3.0)
  12. Jan 30, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  13. Feb 2, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 2, 2026, Yoshiaki Fujimori informed Boston Scientific Corporation (the “Company”) that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).”
  14. Feb 2, 2026Insider · 1 personInsiders: 2 sales (~$15.0M)
  15. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  16. Feb 10, 2026FDAFDA device clearance: SpaceOAR Vue System (SV-2101)
  17. Feb 10, 2026FDARecall: EndoVive Safety PEG Kit; Outer Box Material Number (UPN): M00509001; Inner Box Material Number (UPN): M00509000;
  18. Feb 10, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  19. Feb 12, 2026Federal contract · $519K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $519K obligated to date
  20. Feb 18, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors (and 1 more item)“On February 18, 2026 the Board of Directors (the “ Board ”) of Boston Scientific Corporation (the “ Company ”), upon the recommendation of the Nominating and Governance Committee of the Board, increased the number of directors comprising the Board from ten to twelve, and appointed each of Catherine R. Smith and Christophe P. Weber to be a director of the Company, to hold office until the next annual meeting of…”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC

The full history of Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data